Publications by authors named "M A Schechter"
Introduction: There are limited data regarding the associations between public transportation reliance, availability, and diabetic foot ulcer (DFU)-related amputations.
Research Design And Methods: We used visit-level data from the Georgia 2016-2019 Healthcare Cost and Utilization Project database and obtained transportation variables from open sources. Using Bayesian spatial-temporal models, we assessed the associations between transportation and DFU-related amputations within each quartile of poverty status indicators at the ZIP code tabulation area (ZCTA) level.
Article Synopsis
- * Over 8 weeks, participants' mental health was assessed and compared to a treatment-as-usual group, revealing significant short-term improvements in depression symptoms shortly after the intervention.
- * While the UPLIFT group showed a notable reduction in depression symptoms (PHQ-9 scores) immediately post-treatment, changes in anxiety symptoms (GAD-7 scores) were not statistically confirmed, suggesting future research is needed.
Deciphering the spectrum and founder disease-causing variants (DCVs) in specific populations can shape and facilitate the diagnostic process of Lynch Syndrome (LS). The aim of this report was to comprehensively update on the genetic landscape of LS in the ethnically diverse Israeli-Jewish population. The cohort included 1080 carriers from 588 families; some from underrepresented, understudied Israeli ethnic groups recruited from 8 genetic institutes and high-risk clinics throughout the country.
View Article and Find Full Text PDFArticle Synopsis
- * A study examined hospitalized patients with midline catheters to see if the tip's location (arm vs. axillary vein) affected the incidence of midline catheter-associated thrombosis (MCAT).
- * Results showed no significant increase in MCAT risk for catheters placed in the axillary vein compared to those in the arm, suggesting that current guidelines against axillary placement may need to be reevaluated.
High Prescription Rate of Medications With Rifampin Drug-drug Interactions in Patients With Diabetic Foot Osteomyelitis: Should Rifabutin Be Included in Clinical Trials for Adjunctive Therapy?
Open Forum Infect Dis
November 2024
Article Synopsis
- Rifampin has potential benefits for treating diabetic foot osteomyelitis, but it has many drug interactions that could complicate its use.
- A study examined medications of 190 patients with this condition.
- The findings suggest that rifabutin, which has fewer interactions, could be a more practical alternative for treatment.